Overview

Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia

Status:
Completed
Trial end date:
2018-12-30
Target enrollment:
Participant gender:
Summary
To compare intravenous levofloxacin and ciprofloxacin regarding their risk on the corrected QT interval (QTc) prolongation and dysglycemia in diabetic and non-diabetic patients.
Phase:
Phase 4
Details
Lead Sponsor:
Beni-Suef University
Treatments:
Ciprofloxacin
Levofloxacin
Ofloxacin